US EditionAlafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair – Ortho Spine News
Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Alafair Biosciences Announces First Patient Enrolled in Multi-Center Study Evaluating VersaWrap® Tendon Protector for Achilles Repair – Ortho Spine News
VersaWrap® Hydrogel Sheet AUSTIN, Texas, June 25, 2025 /PRNewswire/ — Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle Orthopaedics Clinic, as part of a prospective, multi-center, controlled case series evaluating the clinical outcomes of VersaWrap® in Achilles tendon repair. This B.R.A.A.D study, which stands for “Better Recovery, Hyaluronic
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
